Browse > Article
http://dx.doi.org/10.4333/KPS.2010.40.1.039

Preparation and Evaluation of Freeze-dried Solid Lipid Nanoparticles with Various Cryoprotectants  

Li, Ri Hua (College of Pharmacy, Woosuk University)
Seo, Seung-Yong (College of Pharmacy, Woosuk University)
Eun, Jae-Soon (College of Pharmacy, Woosuk University)
Lee, Mi-Kyung (Department of Pharmaceutical Engineering, Woosuk University)
Publication Information
Journal of Pharmaceutical Investigation / v.40, no.1, 2010 , pp. 39-43 More about this Journal
Abstract
Solid lipid nanoparticles (SLNs) were freeze-dried to obtain a stable solid dosage form with the aid of various cryoprotectants such as trehalose, sucrose, glucose, fructose, and glycerol. Tricaprin(TC) and trilaurin(TL) were used as lipid matrices for SLNs and stabilizers were egg phosphatidylcholine and pegylated phospholipid. All cryoprotectants tested did not cause changes in mean particle size of SLNs when mixed with SLNs before freeze-drying. However, the mean particle sizes of reconstituted SLNs after freeze-drying were significantly different from those of the un-lyophilized original SLN dispersions depending on the types and concentration of cryoprotectants. Although the freeze-dried SLNs without any cryoprotectants were easily reconstituted by hand-shaking, the mean particle size drastically increased (> $8\;{\mu}m$ for TC SLNs and around $1\;{\mu}m$ for TL SLNs) compared to that of un-lyophilized original dispersion (97 nm for TC SLNs and 164 nm for TL SLNs). Trehalose and sucrose were the most effective additives to protect the SLNs during lyophilization. The reconstituted SLNs were physically stable for 24 hours when lyophilized with 12.5% trehalose, sucrose, glucose, fructose or glycerol.
Keywords
solid lipid nanoparticles; tricarprin; trilaurin; freeze-drying; cryoprotectants;
Citations & Related Records
연도 인용수 순위
  • Reference
1 B. Siekmann and K. Westesen, Submicron-sized parenteral carrier systems based on solid lipids. Pharm. Pharmacol. Lett. 1, 123-126 (1992).
2 M.D. Josh and R.H. Muller, Lipid nanoparticles for parenteral delivery of actives, Eur. J. Pharm. 71, 161-72 (2008).   DOI
3 C. Schwartz and W. Mehnert, Freeze-drying of drug-free and drug-loaded solid lipid nanoparticles (SLN), Int. J. Pharm, 157, 171-179 (1997).   DOI
4 A. Misra, K. Jinturkar, D. Patel, J. Lalani and M. Chougule, recent advances in liposomal dry powder formulations: preparation and evaluation, Expert Opin. Drug Deliv. 6, 71-89 (2009).   DOI
5 A.C.Bach, J. Ferezou, and A. Frey, Phospholipid-rich particles in commercial parenteral fat emulsions. An overview, Prog. Lipid Res. 35, 133-53 (1996)   DOI
6 C. Schwartz, J.S. Mehnert, J.S. Lucks, R.H. Muller, Solid lipid nanoparticles (SLN) for controlled drug delivery. I. Production, characterization and sterilization, J. Control. Rel. 30, 83-96. (1994).   DOI
7 M. Grit and D.J.A. Crommelin, The effect of aging on the physical stability of liposome dispersions, Chem. Phys. Lipids. 62, 113-122. (1992).   DOI
8 M.F. Powell, T. Nguyen and L. Baloian, Compendium of excipients for parenteral formulations, PDA J. Pharm. Sci. Tech. 52, 238-311 (1998).
9 Y.N.Konan, R. Gurny, and E. Allermann, Preparation and characterization of sterile and freeze-dried sub-200nm nanoparticles, Int. J. Pharm. 354, 242-247 (2002)   DOI
10 S. Kamiya, T. Kurita, A. Miyagishima and M. Arakawa, Preparation of griseofulvin nanoparticle suspension by high-pressure homogenization and preservation of the suspension with saccharides and sugar alcohols, Drug Dev. Ind. Pharm. 38, 1022-8 (2009).   DOI
11 M. Ausborn, P. Nuhn, P. and H. Schreier, Stabilization of liposomes by freeze-thaw and lyophilization techniques: problems and opportunities, Eur. J. Pharm. Biopharm. 38, 133-139 (1992).
12 G. Strauss, P. Schurtenberger, P. and H. Hauser, The interaction of saccharides with lipid bilayer vesicles: stabilization during freeze-thawing and freeze-drying, Biochim. Biophys. Acta. 858, 169-180 (1986).   DOI   ScienceOn
13 C. Freitas and R.H. Muller, Effect of light and temperature on zeta potential and physical stability in solid lipid nanoparticles ($SLN^{TM}$) dispersion, Int. J. Pharm. 168, 221-229 (1998).   DOI
14 L. Zhang, L. liu, Y. Qian, and Y. Chen, The effect of cryoprotectants on the freeze-drying of ibuprofen-loaded solid lipid microparticles (SLM), Eur. J. Pharm. Biopharm. 69, 750-759 (2008).   DOI
15 H. Ohshima, A. Migagishima, T. Kurita, Y. Makino, Y. Iwao, T. Sonobe and S. Itai, Freeze-dried nifedifine-lipid nanoparticles with long-term nano-dispersion stability after reconstitution, Int. J. Pharm. 377, 180-184 (2008).   DOI
16 D. Law, W. Wang, E.A. Schmitt, Y. Qiu, S.L. Krill, and J.J.Fort, Properties of rapidly dissolving eutectic mixtures of poly (ethylene glycol) and fenofibrate: the eutectic microstructure, J. Pharm. Sci. 92, 505-515 (2003).   DOI
17 M.G. Anhorn, H.C. Mahler, K. Langer, Freeze-drying of human serum albumin (HSA) nanoparticles with different excipients, Int. J. Pharm. 363, 162-169 (2008).   DOI
18 P.D.Marcato and N. Duran, New aspects of nanopharmaceutical delivery systems, J. Nanosci. Nanotechnol., 8, 2216-29 (2008).   DOI